The government’s top infectious disease expert, Anthony Fauci, recently reported that the United States might be able to return to what resembled our old normal by Spring 2022. Earlier this year, Fauci announced that by Summer 2021, life would be back to normal, but the Delta variant of Covid-19 derailed the timeline.
Tag: Delta Variant
Health Officials Worried About ‘Twindemic’ as Flu Season Approaches and Covid Cases are on the Rise
As the United States approaches the beginning of another flu season and as Covid-19 cases continue amounting around the country, especially with the new Delta variant, health officials urge Americans to take their flu shot.
Covid-19 Booster Shots Available for All Americans Starting 9/20
U.S. health officials and medical experts have announced on Wednesday that booster doses of COVID-19 will be offered starting as soon as Sept. 20. The news came after cases of the COVID, and Delta variant have been increasing all over the country over the past few weeks.
Florida Launches Covid Antibody Treatment “Strike Team” as Patients Floods Hospitals
As Florida struggles with record-high hospitalizations, the state is launching a rapid response unit to administer monoclonal antibody therapies to residents fighting COVID-19. They are also developing “strike teams” to distribute the treatment directly to long term care facilities.
U.S. Employment Surges in July, Unemployment Drops to 5.4%
The U.S.’s hiring has surged in the last month. According to AP News, U.S. employers added 943,000 jobs and unemployment dropped to 5.4%, which is some much-needed good news for the U.S. economy as it continues to bounce back from last year’s shutdown.
Delta-Plus Variant Cases Recorded in South Korea
On Tuesday, South Korea’s Disease Control and Prevention Agency reported that it had recorded at least two cases of the new delta-plus variant of the coronavirus. They told Reuters that the first case was a man in his 40s with “no recent travel records.” The second was recorded in a person who received both doses of the AstraZeneca coronavirus vaccine, returning to South Korea from the U.S.
